Cargando…

Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva

Containment of SARS-CoV-2 has become an urgent global issue. To overcome the problems of conventional quantitative polymerase chain reaction (qPCR) tests, we verified the usefulness of a mobile qPCR device that utilizes mouthwash to obtain a saliva sample with the aim of developing a rapid diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuyama-Toda, Reiko, Muraoka, Masaaki, Terada-Ito, Chika, Ide, Shinji, Horiuchi, Toshikatsu, Amemiya, Tsuyoshi, Fukuoka, Airi, Hamada, Yoshiki, Sejima, Shunsuke, Satomura, Kazuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625231/
https://www.ncbi.nlm.nih.gov/pubmed/34829371
http://dx.doi.org/10.3390/diagnostics11112024
_version_ 1784606369024835584
author Tokuyama-Toda, Reiko
Muraoka, Masaaki
Terada-Ito, Chika
Ide, Shinji
Horiuchi, Toshikatsu
Amemiya, Tsuyoshi
Fukuoka, Airi
Hamada, Yoshiki
Sejima, Shunsuke
Satomura, Kazuhito
author_facet Tokuyama-Toda, Reiko
Muraoka, Masaaki
Terada-Ito, Chika
Ide, Shinji
Horiuchi, Toshikatsu
Amemiya, Tsuyoshi
Fukuoka, Airi
Hamada, Yoshiki
Sejima, Shunsuke
Satomura, Kazuhito
author_sort Tokuyama-Toda, Reiko
collection PubMed
description Containment of SARS-CoV-2 has become an urgent global issue. To overcome the problems of conventional quantitative polymerase chain reaction (qPCR) tests, we verified the usefulness of a mobile qPCR device that utilizes mouthwash to obtain a saliva sample with the aim of developing a rapid diagnostic method for SARS-CoV-2. First, we examined whether anyone could easily operate this device. Then, we examined whether RNA in the mouthwash could be detected in a short time. In addition, we investigated whether it was possible to diagnose SARS-CoV-2 infection using mouthwash obtained from COVID-19 patients undergoing hospitalization. The results revealed that all subjects were able to complete the operation properly without error. In addition, RNase P was detected in the mouthwash without pretreatment. The average detection time was 18 min, which is significantly shorter than conventional qPCR devices. Furthermore, this device detected SARS-CoV-2 in the mouthwash of a COVID-19 patient undergoing hospitalization. The above findings verified the efficacy of this diagnostic method, which had a low risk of infection, was technically simple, and provided stable results. Therefore, this method is useful for the rapid detection of SARS-CoV-2.
format Online
Article
Text
id pubmed-8625231
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86252312021-11-27 Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva Tokuyama-Toda, Reiko Muraoka, Masaaki Terada-Ito, Chika Ide, Shinji Horiuchi, Toshikatsu Amemiya, Tsuyoshi Fukuoka, Airi Hamada, Yoshiki Sejima, Shunsuke Satomura, Kazuhito Diagnostics (Basel) Article Containment of SARS-CoV-2 has become an urgent global issue. To overcome the problems of conventional quantitative polymerase chain reaction (qPCR) tests, we verified the usefulness of a mobile qPCR device that utilizes mouthwash to obtain a saliva sample with the aim of developing a rapid diagnostic method for SARS-CoV-2. First, we examined whether anyone could easily operate this device. Then, we examined whether RNA in the mouthwash could be detected in a short time. In addition, we investigated whether it was possible to diagnose SARS-CoV-2 infection using mouthwash obtained from COVID-19 patients undergoing hospitalization. The results revealed that all subjects were able to complete the operation properly without error. In addition, RNase P was detected in the mouthwash without pretreatment. The average detection time was 18 min, which is significantly shorter than conventional qPCR devices. Furthermore, this device detected SARS-CoV-2 in the mouthwash of a COVID-19 patient undergoing hospitalization. The above findings verified the efficacy of this diagnostic method, which had a low risk of infection, was technically simple, and provided stable results. Therefore, this method is useful for the rapid detection of SARS-CoV-2. MDPI 2021-11-01 /pmc/articles/PMC8625231/ /pubmed/34829371 http://dx.doi.org/10.3390/diagnostics11112024 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tokuyama-Toda, Reiko
Muraoka, Masaaki
Terada-Ito, Chika
Ide, Shinji
Horiuchi, Toshikatsu
Amemiya, Tsuyoshi
Fukuoka, Airi
Hamada, Yoshiki
Sejima, Shunsuke
Satomura, Kazuhito
Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_full Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_fullStr Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_full_unstemmed Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_short Feasibility of Rapid Diagnostic Technology for SARS-CoV-2 Virus Using a Trace Amount of Saliva
title_sort feasibility of rapid diagnostic technology for sars-cov-2 virus using a trace amount of saliva
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625231/
https://www.ncbi.nlm.nih.gov/pubmed/34829371
http://dx.doi.org/10.3390/diagnostics11112024
work_keys_str_mv AT tokuyamatodareiko feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT muraokamasaaki feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT teradaitochika feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT ideshinji feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT horiuchitoshikatsu feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT amemiyatsuyoshi feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT fukuokaairi feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT hamadayoshiki feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT sejimashunsuke feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva
AT satomurakazuhito feasibilityofrapiddiagnostictechnologyforsarscov2virususingatraceamountofsaliva